AI-generated summary
This literature review summarizes preclinical and clinical studies on exosomes as possible regenerative treatments for alopecia. The authors report that preclinical studies show benefits for hair loss, while efficacy and safety data for alopecia in humans are lacking, and no relevant clinical trials were identified. The review also notes gaps in knowledge about safety, exosome source, and delivery and dosage.
- Studies included
- 47
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract states that clinical data showing efficacy and safety for alopecia are lacking and that no relevant clinical trials were identified.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.